Jaime Ruszkowski
Internal Medicine · Trumbull, CTNPI 1811160906
Payments from drug & device makers
Across 90 payments — averaging $25.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$556
- AstraZeneca$349
- Boehringer Ingelheim$308
- Exact Sciences$177
- Kaleo, Inc.$128
- Pfizer$113
- plus $682 from 16 others
What the payments were for
- Food & beverage$2,29499%
- Education$201%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 21 | $556 |
| AstraZeneca(2 entities) | 14 | $349 |
| Boehringer Ingelheim | 5 | $308 |
| Exact Sciences | 8 | $177 |
| Kaleo, Inc. | 6 | $128 |
| Pfizer | 6 | $113 |
| Lilly USA, LLC | 4 | $91 |
| Myriad Women's Health, Inc. | 1 | $90 |
| Bayer | 3 | $69 |
| Amgen | 3 | $63 |
| AbbVie | 3 | $54 |
| Merck | 2 | $50 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Tris Pharma Inc | 2 | $34 |
| Astellas Pharma US Inc | 1 | $27 |
| Corcept Therapeutics | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $19 |
| Intra-sana Laboratories | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Vertical Pharmaceuticals, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,314 in reported general payments places this provider in the 85th percentile of 2,067 internal medicine providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 25 | $37,060 |
| MyrbetriqMirabegron | 25 | $22,696 |
| JardianceEmpagliflozin | 16 | $22,304 |
| MounjaroTirzepatide | 14 | $15,011 |
| SynthroidLevothyroxine Sodium | 38 | $3,204 |
| Atorvastatin Calcium | 147 | $1,558 |
| Rosuvastatin Calcium | 128 | $1,472 |
| Levothyroxine Sodium | 98 | $1,026 |
| Nebivolol Hcl | 11 | $983 |
| Temazepam | 11 | $970 |
| Zafirlukast | 14 | $824 |
| Irbesartan | 20 | $775 |
| Omeprazole | 39 | $772 |
| Clonazepam | 18 | $699 |
| Fluoxetine Hcl | 28 | $620 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $556 | $37,06025 claims |
| Astellas Pharma US IncMyrbetriq | $27 | $22,69625 claims |
| Boehringer IngelheimJardiance | $308 | $22,30416 claims |
| Lilly USA, LLCMounjaro | $91 | $15,01114 claims |
| AbbVieSynthroid | $54 | $3,20438 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,067 internal medicine providers in Connecticut.
Other internal medicine in Trumbull
- Michelle MallitzTrumbull$971K
- Amit MahajanTrumbull$36K
- Joseph SouferWaterbury$21.5M
- David RadinStamford$7M
- Steven RyderWestport$3.9M
- Nancy BrownNew Haven$2.8M
- Charles MontanoCromwell$2.8M
- Arthur DecillisMadison$1M
- Allen HellerWoodbridge$758K
- Gary BlickNorwalk$717K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.